8338.T
Tsukuba Bank, Ltd.
TokyoJPYEQUITY
Financial Services
DELAYED
Last price
694.00
▼ 18.00 (2.53%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
722.00
Prev close
712.00
Day high
723.00
Day low
694.00
Volume
1.26M
Market cap
$57.19B
P/E (TTM)
8.68
52W range
282.00 – 799.00
Day trading desk
Gap from prior close
+1.40%
Prior close 712.00
VWAP
700.42
-0.92% from price
Relative volume
0.65×
Normal
Session range
4.18%
694.00 – 723.00
Position in range
0%
Near session low
ATR (14D)
38.14
5.50% of price
Prior day high
720.00
PDH
Prior day low
694.00
PDL
Bid / ask spread
—
Quote not published
Session volume
1.16M
Avg 1.77M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-9.75%
-8.4%
1M
+4.83%
+1.1%
3M
+8.10%
+5.0%
6M
+3.27%
-7.8%
YTD
+66.83%
+54.5%
1Y
+152.36%
+132.4%
3Y
+235.27%
+161.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 8338.T open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
7.67M
Total on file
Fundamentals
Market cap$57.19B
Enterprise value$-10.62B
Revenue (TTM)$45.73B
Gross profit$45.73B
EBITDA—
Net income$6.93B
EPS (TTM)$79.96
Free cash flow—
Total cash$224.40B
Total debt$155.10B
Book value / share$1,348.98
Shares outstanding82.41M
Float74.85M
Short % of float—
Dividend yield0.70%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E8.68
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.51
EV / revenue-0.23
EV / EBITDA—
Gross margin0.00%
Operating margin19.37%
Profit margin15.32%
Return on equity6.69%
Return on assets0.24%
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $39.05B | $34.26B | $35.49B | $31.97B | +14.0% |
| Operating revenue | $39.05B | $34.26B | $35.49B | $31.97B | +14.0% |
| Selling, general & admin | $23.59B | $22.84B | $22.80B | $23.14B | +3.3% |
| Total operating expense | $31.29B | $28.00B | $29.02B | $26.40B | +11.7% |
| Pre-tax income | $7.01B | $4.38B | $2.50B | $1.81B | +60.2% |
| Tax provision | $340.00M | $273.00M | $302.00M | -$281.00M | +24.5% |
| Net income | $6.67B | $4.10B | $2.19B | $2.10B | +62.6% |
| Net income to common | $6.67B | $4.10B | $2.19B | $2.10B | +62.6% |
| Basic EPS | 79.97 | 49.79 | 26.58 | 25.35 | +60.6% |
| Diluted EPS | 79.97 | 49.79 | 9.46 | 8.07 | +60.6% |
| Basic shares | 82.39M | 82.34M | 82.34M | 82.50M | +0.1% |
| Diluted shares | 82.39M | 82.34M | 82.34M | 82.50M | +0.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $164.26B | $307.35B | $351.61B | $334.87B | -46.6% |
| Property, plant & equipment | $18.80B | $19.15B | $19.81B | $20.11B | -1.8% |
| Goodwill & intangibles | $3.64B | $3.34B | $3.88B | $4.37B | +8.9% |
| Total assets | $2.84T | $2.89T | $2.85T | $2.77T | -1.9% |
| Total debt | $166.30B | $143.30B | $138.30B | $128.30B | +16.1% |
| Total liabilities | $2.73T | $2.80T | $2.76T | $2.68T | -2.4% |
| Retained earnings | $48.32B | $42.07B | $38.38B | $36.59B | +14.9% |
| Shareholder equity | $105.85B | $91.75B | $97.14B | $91.02B | +15.4% |
| Net tangible assets | $102.21B | $88.40B | $93.26B | $86.65B | +15.6% |
| Shares issued | 82.55M | 82.55M | 82.55M | 82.55M | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $7.01B | $4.38B | $2.50B | $1.81B | +60.2% |
| Depreciation & amortisation | $1.92B | $2.23B | $2.13B | $2.28B | -13.7% |
| Change in working capital | -$164.90B | -$29.80B | $3.75B | -$260.27B | -453.3% |
| Operating cash flow | -$139.59B | -$23.04B | $7.19B | -$261.93B | -505.9% |
| Capital expenditure | -$1.90B | -$1.13B | -$1.59B | -$1.54B | -67.1% |
| Investing cash flow | -$2.21B | -$15.13B | $18.44B | $59.37B | +85.4% |
| Share buybacks | $0 | $0 | -$48.00M | -$18.00M | — |
| Dividends paid | -$415.00M | -$418.00M | -$415.00M | -$412.00M | +0.7% |
| Financing cash flow | -$416.00M | -$419.00M | -$464.00M | -$431.00M | +0.7% |
| Free cash flow | -$141.49B | -$24.17B | $5.60B | -$263.47B | -485.4% |
| End cash position | $161.33B | $303.54B | $342.13B | $316.96B | -46.9% |
| Line item | 2025-06-30 | YoY |
|---|---|---|
| Basic EPS | 20.98 | |
| Diluted EPS | 20.98 | |
| Basic shares | 82.35M | |
| Diluted shares | 82.35M |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $164.26B | $201.63B | $307.35B | -18.5% |
| Property, plant & equipment | $18.80B | $18.89B | $19.15B | -0.4% |
| Goodwill & intangibles | $3.64B | $3.52B | $3.34B | +3.4% |
| Total assets | $2.84T | $2.87T | $2.89T | -1.2% |
| Total debt | $166.30B | $143.30B | $143.30B | +16.1% |
| Total liabilities | $2.73T | $2.77T | $2.80T | -1.4% |
| Retained earnings | $48.32B | $45.44B | $42.07B | +6.3% |
| Shareholder equity | $105.85B | $102.70B | $91.75B | +3.1% |
| Net tangible assets | $102.21B | $99.18B | $88.40B | +3.1% |
| Shares issued | 82.55M | 82.55M | 82.55M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | — | 25.04 | — |
| Dec 2025 | — | 23.16 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders9.31%
Held by institutions13.19%
Institutions holding27
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
719.00
-3.48% from price
SMA 20
684.35
+1.41% from price
SMA 50
659.02
+5.31% from price
SMA 100
635.32
+9.24% from price
SMA 200
562.28
+23.43% from price
EMA 12
706.21
-1.73% from price
EMA 26
685.38
+1.26% from price
EMA 50
665.32
+4.31% from price
RSI (14)
51.8
Neutral
MACD (12,26,9)
20.83
Hist 0.49
ATR (14)
38.14
5.50% of price
Realised vol 30D
61.7%
Annualised
Bollinger upper
778.96
20, 2σ
Bollinger lower
589.74
20, 2σ
50 / 200 cross
Golden
659.02 vs 562.28
Trend bias
Above 200
+23.43%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
61.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-24.6%
Peak to trough
Max drawdown 5Y
-46.6%
Peak to trough
ATR 14
38.14
5.50% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate$5.00 / yr
Forward yield0.70%
5-year avg yield2.20%
Payout ratio6.25%
Ex-dividend dateMar 30, 2027
Next pay date—
Last split—
Split date—
Headlines
Oleria and Happiest Minds Partner to Accelerate Modern Identity Governance for AI-First Enterprises
ACCESS Newswire · 6m ago
Vicore Pharma to Present at the European Respiratory Society Congress 2026
ACCESS Newswire · 6m ago
Dollar trading near multi-month lows, restrained by debt nerves
Reuters · 6m ago
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 16m ago
TME Pharma provides update on its activities
GlobeNewswire · 16m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 21m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 21m ago
Board Update
GlobeNewswire · 21m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.